Uncontrolled gelatin degradation in non-healing chronic wounds
- 2 November 2018
- journal article
- research article
- Published by Mark Allen Group in Journal of Wound Care
- Vol. 27 (11) , 724-734
Abstract
Objective: To compare matrix metalloproteinase (MMP)-9 and the antiproteinase tissue inhibitor of metalloproteinases (TIMP)-1 in wound fluids and sera from patients with chronic non-healing or acute healing wounds. In addition, the functional consequences on MMP-9 activity and general gelatinase activity were assessed.Method: In this observational study, samples were collected from patients with venous leg ulcers (VLUs), patients with type 2 diabetes with neuropathic foot ulcers (DFUs), and from another cohort of VLU patients with sterile split-thickness skin graft donor sites after autologous skin grafting, serving as healing control wounds. MMP-9 and TIMP-1 concentrations were determined by enzyme-linked immunosorbent assays. MMP-9 and gelatinase activities were determined in wound fluids in subsets of the patients.Results: A total of 24 patients took part in the study. No significant differences in MMP-9 wound fluid levels were found among the three groups. TIMP-1 levels were markedly and significantly lower in the two chronic wound groups resulting in a severely unbalanced MMP-9/TIMP-1 ratio, especially notable in the VLU group and possibly in the elevated endogenous MMP-9 activity (p<0.01) compared with the acute wound fluids. At least 20% of the chronic wound fluids displayed atypical patterns on gelatin zymography and showed high general gelatinase activity that was not inhibited by either TIMP-1 or by a gelatinase inhibitor (AG3340). MMP-9 levels were higher in the sera of the patients with type 2 diabetes.Conclusion: We hypothesise that non-MMP proteinases contribute to matrix destruction in a significant number of chronic wounds. Blocking the excessive MMP-9 activity may be insufficient to normalise wound healing. The reasons and effects of the very low TIMP-1 levels in chronic wounds need further clarification.Keywords
This publication has 59 references indexed in Scilit:
- Proteolytic Activity by Multiple Bacterial Species Isolated From Chronic Venous Leg Ulcers Degrades Matrix SubstratesBiological Research For Nursing, 2012
- Matrix metalloproteinase inhibition delays wound healing and blocks the latent transforming growth factor-β1-promoted myofibroblast formation and functionWound Repair and Regeneration, 2010
- Matrix metalloproteinase-9 delays wound healing in a murine wound modelSurgery, 2010
- Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesisMatrix Biology, 2009
- Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot UlcersDiabetes Care, 2009
- Proteolytic Activation of Matrix Metalloproteinase-9 in Skin Wound Healing Is Inhibited by α-1-AntichymotrypsinJournal of Investigative Dermatology, 2008
- Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP‐1 to TIMP‐1 is a predictor of wound healingDiabetic Medicine, 2008
- Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjectsDiabetes & Metabolism, 2007
- Surrogate Endpoints for the Treatment of Venous Leg UlcersJournal of Investigative Dermatology, 2002
- Matrix metalloproteinase 9 level predicts optimal collagen deposition during early wound repair in humansBritish Journal of Surgery, 1998